← back to search

Christopher D. Pilcher

University of California, San Francisco · US
Area of research
Infectious Diseases · Virology
Research interest
Research interests include HIV Research and Treatment, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, and HIV, Drug Use, Sexual Risk.
h-index
51
citations
8,874
works
160
NIH funding
primary concept
email

Recent publications

Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease
Nature Communications 2024cited by 23position: middledoi
TCF-1 regulates HIV-specific CD8+ T cell expansion capacity
JCI Insight 2020cited by 86position: middledoi
Group Testing for Severe Acute Respiratory Syndrome– Coronavirus 2 to Enable Rapid Scale-up of Testing and Real-Time Surveillance of Incidence
The Journal of Infectious Diseases 2020cited by 45position: firstdoi
RAPID antiretroviral therapy
AIDS 2018cited by 147position: middledoi
Clinical and public health implications of acute and early HIV detection and treatment: a scoping review
Journal of the International AIDS Society 2017cited by 140position: middledoi
Semen amyloids participate in spermatozoa selection and clearance
eLife 2017cited by 73position: middledoi
The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting
JAIDS Journal of Acquired Immune Deficiency Syndromes 2016cited by 256position: firstdoi
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy
The Journal of Infectious Diseases 2015cited by 144position: middledoi
Gut-Resident Lactobacillus Abundance Associates with IDO1 Inhibition and Th17 Dynamics in SIV-Infected Macaques
Cell Reports 2015cited by 99position: middledoi
Efficient Identification of HIV Serodiscordant Couples by Existing HIV Testing Programs in South Brazil
PLoS ONE 2015cited by 88position: firstdoi
Select host restriction factors are associated with HIV persistence during antiretroviral therapy
AIDS 2015cited by 54position: middledoi
Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository
AIDS 2014cited by 145position: middledoi
Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease
AIDS 2014cited by 118position: middledoi
Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen
Nature Communications 2014cited by 113position: middledoi
How can we better identify early HIV infections?
Current Opinion in HIV and AIDS 2014cited by 71position: middledoi
Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection
Retrovirology 2014cited by 53position: middledoi
Antiretroviral Therapy Initiated Within 6 Months of HIV Infection Is Associated With Lower T-Cell Activation and Smaller HIV Reservoir Size
The Journal of Infectious Diseases 2013cited by 330position: middledoi
Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient
PLoS Pathogens 2013cited by 290position: middledoi
HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus
Virology 2013cited by 116position: middledoi
HIV-1 Vif Adaptation to Human APOBEC3H Haplotypes
Cell Host & Microbe 2013cited by 107position: middledoi
“Taking a Half Day at a Time:” Patient Perspectives and the HIV Engagement in Care Continuum
AIDS Patient Care and STDs 2013cited by 83position: middledoi
Performance of Rapid Point-of-Care and Laboratory Tests for Acute and Established HIV Infection in San Francisco
PLoS ONE 2013cited by 66position: firstdoi
Seroadaptive Practices: Association with HIV Acquisition among HIV-Negative Men Who Have Sex with Men
PLoS ONE 2012cited by 118position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Frederick Hecht · University of California, San Francisco10 papers (2013–2015)Steven G. Deeks · University of California, San Francisco5 papers (2013–2015)Hiroyu Hatano · University of California, San Francisco4 papers (2013–2016)Michael P. Busch · Vitalant4 papers (2013–2014)Elizabeth Sinclair · Wellcome Sanger Institute3 papers (2013–2015)Jeffrey N. Martin · Global Solutions for Infectious Diseases3 papers (2014–2014)Peter Bacchetti · University of California, San Francisco3 papers (2013–2018)Joseph M. McCune · Gates Foundation3 papers (2013–2015)Peter W. Hunt · University of California, San Francisco3 papers (2013–2015)Diane Jones · United in Health2 papers (2016–2018)Monica Gandhi · Chan Zuckerberg Initiative (United States)2 papers (2016–2018) · 2 papers (2014–2017)Leslie R. Cockerham · Medical College of Wisconsin2 papers (2014–2015)Vivek Jain · George Washington University2 papers (2013–2014)Myron S. Cohen · University of North Carolina at Chapel Hill2 papers (2014–2017)Shelley N. Facente · Virginia Department of Health2 papers (2013–2014)Wendy Hartogensis · University of California, San Francisco2 papers (2013–2016)Elvin Geng · Washington University in St. Louis2 papers (2013–2016) · 2 papers (2014–2017)Esper G. Kallás · Instituto Butantan2 papers (2014–2015)